Nutritional Growth Solutions Ltd. (ASX:NGS)
Australia flag Australia · Delayed Price · Currency is AUD
0.0180
-0.0010 (-5.26%)
Mar 13, 2026, 9:59 AM AEST

ASX:NGS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1.632.482.982.953.04
Revenue Growth (YoY)
-34.42%-16.86%1.26%-3.06%62.57%
Cost of Revenue
1.371.672.141.511.68
Gross Profit
0.260.810.841.441.36
Selling, General & Admin
1.883.423.625.45.2
Research & Development
-0.220.290.390.9
Operating Expenses
1.883.643.915.786.09
Operating Income
-1.62-2.83-3.07-4.34-4.73
Interest Expense
-0.31-0.08-0.07-0.02-0.07
Interest & Investment Income
0.220.010.250.110.02
Pretax Income
-1.71-2.9-2.89-4.25-4.78
Net Income
-1.71-2.9-2.89-4.25-4.78
Net Income to Common
-1.71-2.9-2.89-4.25-4.78
Shares Outstanding (Basic)
-69191310
Shares Outstanding (Diluted)
-69191310
Shares Change (YoY)
-257.22%48.60%26.45%121.16%
EPS (Basic)
--0.04-0.15-0.33-0.47
EPS (Diluted)
--0.04-0.15-0.33-0.47
Free Cash Flow
-1.21-1.93-2.35-4.83-3.82
Free Cash Flow Per Share
--0.03-0.12-0.37-0.37
Gross Margin
15.67%32.69%28.22%48.80%44.77%
Operating Margin
-99.57%-114.15%-102.92%-147.40%-155.69%
Profit Margin
-105.10%-116.85%-96.95%-144.18%-157.24%
Free Cash Flow Margin
-74.43%-77.59%-78.65%-164.00%-125.66%
EBITDA
-1.6-2.8-3.01-4.32-4.63
EBITDA Margin
-98.59%-112.90%-100.94%-146.62%-152.40%
D&A For EBITDA
0.020.030.060.020.1
EBIT
-1.62-2.83-3.07-4.34-4.73
EBIT Margin
-99.57%-114.15%-102.92%-147.40%-155.69%
Advertising Expenses
-1.231.41.181.15
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.